Pediatrix Medical (PDX) Lowers Guidance
More News related to PDX
- Pediatrix Medical Name Change to MEDNAX Effective Today
- Pediatrix Medical (PDX) Acquires Tampa Bay Maternal Fetal Group Practice
- Wasserman Initiates Coverage on Pediatrix Medical Group (PDX) with a Buy
- Pediatrix Medical (PDX) Reports In-Line Q3; Guides
- Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
More News related to Guidance
- Toll (TOL) Reports Preliminary Q4, FY09 Results
- China Digital TV (STV) Misses Q3 EPS by 2c; Guides Below for Q4
- AirMedia Group (AMCN) Tops Q3 EPS by 3c; Guides In-line for Q4
- Maidenform Brands (MFB) Reports Mixed Q3 Earnings; Guides Q4, Raises FY09 Outlook
- Emdeon (EM) Tops Q3 EPS by 2c; Guides In-line for FY09
Pediatrix Medical Group, Inc., (NYSE: PDX) is revising its earnings guidance for the 2008 third quarter. PDX now expects EPS of $0.81-$0.83, versus prior guidance of $0.84-$0.87.
During the 2008 third quarter, Pediatrix experienced a shift in reimbursement for patient care from commercial payors to government payors. In addition, same-unit neonatal intensive care unit (NICU) patient volume is expected to be at the lower end of the Company’s guided range, which was an anticipated decline of 1 to 4 percent.
Related Categories
GuidanceHot List
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
